Igor A. Eisenach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Igor A. Eisenach has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Elena L. Lushnikova
Institute of Molecular Pathology and Pathomorphology, Federal Research Center for Fundamental and Translational Medicine, 2 Timakova St., Novosibirsk 630117, Russia
4 shared publications - Galina A. Lapii
Institute of Molecular Pathology and Pathomorphology, Federal Research Center for Fundamental and Translational Medicine, 2 Timakova St., Novosibirsk 630117, Russia
4 shared publications - Aleksey V. Kuznetsov
Federal State Budgetary Educational Institution of Higher Education, Novosibirsk State Medical University, Ministry of Health of Russia, 52 Krasniy Prospekt, Novosibirsk 630091, Russia
3 shared publications - Anastasiya O. Solovieva
Research Institute of Clinical and Experimental Lymphology, Siberian Branch of Russian Academy of Sciences, 6 Arbuzova St., Novosibirsk 630060, Russia
3 shared publications - Victor N. Ovchinnikov
Research Institute of Clinical and Experimental Lymphology – Branch of Institute of Cytology and Genetics of SB RAS
3 shared publications - Aleksandra Pichigina
Institute of Molecular Pathology and Pathomorphology, Federal Research Center for Fundamental and Translational Medicine, Novosibirsk 630117, Russia
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (10) , 496
Comparative Analysis of the Fibroblastic Response and Collagen and Elastic Fiber Formation After Implantation of Polypropylene Versus an Electrospun Biodegradable Polymer for Reinforcement of the Musculo-Fascial Wall
The replacement of polypropylene with biodegradable polymers for surgical reinforcement of musculo-fascial structures is of considerable clinical interest. A study in 98 laboratory rats with implanted polypropylene or biodegradable biopolymer demonstrated the formation of dense irregular connective tissue at the surgical site instead of biopolymer and dense regular connective tissue around the polypropylene. The fibroblastic response to the biopolymer lagged behind that to polypropylene by approximately nine months, reflecting gradual polymer degradation, but did not differ between groups at 12 months, when the biopolymer had completely biotransformed. In both groups, newly formed connective tissue contained numerous elastic fibers and relatively fewer type I (COLI) and type III (COLIII) collagen fibers compared with intact preoperative tissue. In peri-implant tissue from both groups, COLIII fibers significantly predominated over COLI, with a higher volume fraction of COLIII around the polypropylene than around the biopolymer, whereas COLI was significantly more abundant in intact tissues. These findings are consistent with the good extensibility and low tear resistance of newly formed connective tissue. In the polypropylene group, polymer filaments reinforced this tissue mechanically. Further analysis of explanted tissues is required to determine the functional properties of connective tissue remodeled at the site of a degraded biopolymer implant.
- 1 October 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (10) , 496
Open AccessComparative Analysis of the Fibroblastic Response and Collagen and Elastic Fiber Formation After Implantation of Polypropylene Versus an Electrospun Biodegradable Polymer for Reinforcement of the Musculo-Fascial Wall
The replacement of polypropylene with biodegradable polymers for surgical reinforcement of musculo-fascial structures is of considerable clinical interest. A study in 98 laboratory rats with implanted polypropylene or biodegradable biopolymer demonstrated the formation of dense irregular connective tissue at the surgical site instead of biopolymer and dense regular connective tissue around the polypropylene. The fibroblastic response to the biopolymer lagged behind that to polypropylene by approximately nine months, reflecting gradual polymer degradation, but did not differ between groups at 12 months, when the biopolymer had completely biotransformed. In both groups, newly formed connective tissue contained numerous elastic fibers and relatively fewer type I (COLI) and type III (COLIII) collagen fibers compared with intact preoperative tissue. In peri-implant tissue from both groups, COLIII fibers significantly predominated over COLI, with a higher volume fraction of COLIII around the polypropylene than around the biopolymer, whereas COLI was significantly more abundant in intact tissues. These findings are consistent with the good extensibility and low tear resistance of newly formed connective tissue. In the polypropylene group, polymer filaments reinforced this tissue mechanically. Further analysis of explanted tissues is required to determine the functional properties of connective tissue remodeled at the site of a degraded biopolymer implant.
- Open Access
- 2 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 3231
Comparative Evaluation of Tissue and Systemic Responses to Electrospun Biodegradable Polymer and Polypropylene Implants Using hs-CRP and Immunohistochemical Markers
The use of biodegradable polymers for the surgical reinforcement of musculofascial structures is of considerable practical interest. Research into the applicability of biopolymers should be conducted in comparison with polypropylene, a material used in surgery. Using highly sensitive C-reactive protein (hs-CRP) in blood and interleukin-6 (IL-6) and CD34 (an endothelial marker with angiogenic properties) in tissues, we analyzed the systemic and local tissue responses to polypropylene and biodegradable polymer implantation in 42 laboratory rats over a three-month period. The study confirmed good biocompatibility of both polymers. However, the systemic and tissue responses to the biopolymer, as measured by the studied markers, were significantly less pronounced compared to polypropylene. Persistently elevated levels of hs-CRP and CD34-positive cells in the biopolymer group at three months post-implantation were attributed to ongoing biotransformation processes. The mild inflammatory response following biopolymer implantation confirms not only its bioinert properties but also its potential for practical surgical applications. Elevated levels of hs-CRP and CD34-, as well as IL-6-positive cells in the polypropylene group, warrant further investigation of long-term responses to polypropylene as potential contributors to post-implantation complications. The hs-CRP level correlated with tissue markers IL-6 and CD34, suggesting its utility as a criterion for assessing postoperative adaptation to implanted synthetic materials.
- 2 April 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (7) , 3231
Open AccessComparative Evaluation of Tissue and Systemic Responses to Electrospun Biodegradable Polymer and Polypropylene Implants Using hs-CRP and Immunohistochemical Markers
The use of biodegradable polymers for the surgical reinforcement of musculofascial structures is of considerable practical interest. Research into the applicability of biopolymers should be conducted in comparison with polypropylene, a material used in surgery. Using highly sensitive C-reactive protein (hs-CRP) in blood and interleukin-6 (IL-6) and CD34 (an endothelial marker with angiogenic properties) in tissues, we analyzed the systemic and local tissue responses to polypropylene and biodegradable polymer implantation in 42 laboratory rats over a three-month period. The study confirmed good biocompatibility of both polymers. However, the systemic and tissue responses to the biopolymer, as measured by the studied markers, were significantly less pronounced compared to polypropylene. Persistently elevated levels of hs-CRP and CD34-positive cells in the biopolymer group at three months post-implantation were attributed to ongoing biotransformation processes. The mild inflammatory response following biopolymer implantation confirms not only its bioinert properties but also its potential for practical surgical applications. Elevated levels of hs-CRP and CD34-, as well as IL-6-positive cells in the polypropylene group, warrant further investigation of long-term responses to polypropylene as potential contributors to post-implantation complications. The hs-CRP level correlated with tissue markers IL-6 and CD34, suggesting its utility as a criterion for assessing postoperative adaptation to implanted synthetic materials.
- Open Access
- 7 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (4) , 1419
Changes in the Level of hs-CRP in the Blood and Morphometric Parameters of Tissues Following Implantation of Polypropylene
In recent decades, the use of polypropylene meshes has been the gold standard in the surgical treatment of muscular corset failure. However, the reasons behind the low percentage of complications and recurrences remain controversial. Tissue hyperreactivity and the immune response to polypropylene may be contributing factors. Measurements of the level of hs-CRP (highly sensitive C-reactive protein) in the blood and morphometric studies of tissues around the implant were carried out for three months after the installation of polypropylene implants in 53 laboratory rats. The research results confirmed the good biocompatibility of polypropylene and the formation of full-fledged connective tissue around polypropylene three months after the installation of the material. The level of hs-CRP in the blood increased slightly, without significant differences, but in some animals, there was a sharp increase in this indicator at 3 months. Such results may indicate the development of hyperreactivity to the implantation of a synthetic material and, with other accompanying factors, lead to the development of complications both at the local tissue and general immune levels.
- 7 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (4) , 1419
Open AccessChanges in the Level of hs-CRP in the Blood and Morphometric Parameters of Tissues Following Implantation of Polypropylene
In recent decades, the use of polypropylene meshes has been the gold standard in the surgical treatment of muscular corset failure. However, the reasons behind the low percentage of complications and recurrences remain controversial. Tissue hyperreactivity and the immune response to polypropylene may be contributing factors. Measurements of the level of hs-CRP (highly sensitive C-reactive protein) in the blood and morphometric studies of tissues around the implant were carried out for three months after the installation of polypropylene implants in 53 laboratory rats. The research results confirmed the good biocompatibility of polypropylene and the formation of full-fledged connective tissue around polypropylene three months after the installation of the material. The level of hs-CRP in the blood increased slightly, without significant differences, but in some animals, there was a sharp increase in this indicator at 3 months. Such results may indicate the development of hyperreactivity to the implantation of a synthetic material and, with other accompanying factors, lead to the development of complications both at the local tissue and general immune levels.
- Open Access
- 17 October 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (20) , 11183
Application of hs-CRP in Assessment of Tissue Inflammation Following Implantation of Biodegradable Polymer in Experiment
Implants made of biodegradable polymers are replaced by regenerating tissues through inflammation. The changes occurring in tissues and the organism are of practical interest for studying the biocompatibility of the material and searching for systemic markers in the blood that reflect inflammation in peri-implantation tissues. The highly sensitive C-reactive protein (hs-CRP) measurements in blood and morphometric studies of tissue surrounding the implant were carried out in the experiment within three months of implantation of a biopolymer consisting of polycaprolactone (PCL) and polytrimethylene carbonate (PTMC). During the first month, tissue inflammation decreased, and the blood level of hs-CRP did not increase. The polymer biotransformation began in the tissues after a month of implantation and was accompanied by inflammation moving deeper into the matrix. Proliferation of inflammatory cells in tissues was reflected in an increase in the hs-CRP level three months after polymer installation. The result achieved confirmed the polymer’s bioinertness. The level of hs-CRP in the blood of the animals correlated with the level of inflammation in peri-implantation tissues, reflecting the activity of inflammation in the process of polymer biotransformation. This inflammation protein can be recommended for assessing tissue processes following implantation of biopolymers and their biocompatibility.
- 17 October 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (20) , 11183
Open AccessApplication of hs-CRP in Assessment of Tissue Inflammation Following Implantation of Biodegradable Polymer in Experiment
Implants made of biodegradable polymers are replaced by regenerating tissues through inflammation. The changes occurring in tissues and the organism are of practical interest for studying the biocompatibility of the material and searching for systemic markers in the blood that reflect inflammation in peri-implantation tissues. The highly sensitive C-reactive protein (hs-CRP) measurements in blood and morphometric studies of tissue surrounding the implant were carried out in the experiment within three months of implantation of a biopolymer consisting of polycaprolactone (PCL) and polytrimethylene carbonate (PTMC). During the first month, tissue inflammation decreased, and the blood level of hs-CRP did not increase. The polymer biotransformation began in the tissues after a month of implantation and was accompanied by inflammation moving deeper into the matrix. Proliferation of inflammatory cells in tissues was reflected in an increase in the hs-CRP level three months after polymer installation. The result achieved confirmed the polymer’s bioinertness. The level of hs-CRP in the blood of the animals correlated with the level of inflammation in peri-implantation tissues, reflecting the activity of inflammation in the process of polymer biotransformation. This inflammation protein can be recommended for assessing tissue processes following implantation of biopolymers and their biocompatibility.
- Open Access
- 4 January 2024
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 17 (6) , 769-782
Nutritional support during pregnancy
Aim: to summarize new data regarding the effectiveness of nutritional support during pregnancy.Materials and Methods. A search for publications was carried out in the PubMed/MEDLINE, Scopus, Web of Science, RSCI databases by retrieving queries for the following keywords: nutritional support, pregnancy, micronutrients, vitamins, macronutrients, without language restrictions. 71 sources with full text access were selected for analysis.Results. Nutritional status during pregnancy markedly impacts on mother's and neonate’s health. During pregnancy, requirements for macro- and micronutrients increase to maintain maternal homeostasis and support fetal growth. Increasing calorie intake in general female population demonstrates modest effects on pregnancy and fetal outcomes, whereas for pregnant women in poor income countries it results in no long-term benefits for children by assessing their anthropometric parameters and neurocognitive development. Despite the lack of conclusive evidence, in many countries sensible calorie restriction during pregnancy is recommended. Some micronutrients are vital for mother and fetus, because their deficiency is accompanied by increased risk of adverse pregnancy outcomes. For instance, folic acid deficiency is associated with the risk of developing fetal neural tube defects, iodine deficiency is coupled to the risk of emerging pediatric intellectual development disorders associated with congenital hypothyroidism, and calcium deficiency is related to a high risk of maternal hypertensive disorders. Therefore, micronutrient supplementation represents a technology with good potential in fighting for maternal and child health. Nonetheless, despite some advances in understanding nutritional support in pregnant women, many studies provide controversial data substantiating a need to conduct further investigations.Conclusion. Overall, recent year research confirms that the supplementation of micro- and macronutrients during pregnancy is an effective tool for “fetal programming” allowing to impact on maternal and fetal health. At the same time, an analysis of the literature showed a significant lack of research in the field of creating individual nutrition programs and nutritional support for pregnant women belonging to different segments of the population, living in different geographical regions, etc.
- 4 January 2024
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 17 (6) , 769-782
Open AccessNutritional support during pregnancy
Aim: to summarize new data regarding the effectiveness of nutritional support during pregnancy.Materials and Methods. A search for publications was carried out in the PubMed/MEDLINE, Scopus, Web of Science, RSCI databases by retrieving queries for the following keywords: nutritional support, pregnancy, micronutrients, vitamins, macronutrients, without language restrictions. 71 sources with full text access were selected for analysis.Results. Nutritional status during pregnancy markedly impacts on mother's and neonate’s health. During pregnancy, requirements for macro- and micronutrients increase to maintain maternal homeostasis and support fetal growth. Increasing calorie intake in general female population demonstrates modest effects on pregnancy and fetal outcomes, whereas for pregnant women in poor income countries it results in no long-term benefits for children by assessing their anthropometric parameters and neurocognitive development. Despite the lack of conclusive evidence, in many countries sensible calorie restriction during pregnancy is recommended. Some micronutrients are vital for mother and fetus, because their deficiency is accompanied by increased risk of adverse pregnancy outcomes. For instance, folic acid deficiency is associated with the risk of developing fetal neural tube defects, iodine deficiency is coupled to the risk of emerging pediatric intellectual development disorders associated with congenital hypothyroidism, and calcium deficiency is related to a high risk of maternal hypertensive disorders. Therefore, micronutrient supplementation represents a technology with good potential in fighting for maternal and child health. Nonetheless, despite some advances in understanding nutritional support in pregnant women, many studies provide controversial data substantiating a need to conduct further investigations.Conclusion. Overall, recent year research confirms that the supplementation of micro- and macronutrients during pregnancy is an effective tool for “fetal programming” allowing to impact on maternal and fetal health. At the same time, an analysis of the literature showed a significant lack of research in the field of creating individual nutrition programs and nutritional support for pregnant women belonging to different segments of the population, living in different geographical regions, etc.
- 22 March 2019
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 166 (5) , 661-666
Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma
The antimetastatic activity of combined or individual administration of topotecan and tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitor was examined under various administration schedules in mice with Lewis lung carcinoma modeled by intravenous injection of 200,000 clone/mouse. The greatest antimetastatic effect was observed after combined use of topotecan and Tdp1 inhibitor as documented by macroscopic study of the lungs that revealed the decreased metastatic scores by 76, 91, or 74% at the respective inhibitor doses of 2, 4, or 6 mg/mouse, respectively, in parallel with inhibition of metastasis up to 98% (at inhibitor dose of 4 mg/mouse) and morphological and morphometric analyses of the lung sections, which revealed elevation of metastasis growth delay index to 86 and 63% at the respective inhibitor doses of 4 and 6 mg/mouse, respectively. The combined administration of topotecan and Tdp1 inhibitor is viewed as the most effective way to eliminate the metastatic formations with possible restitution of focal lesions.
- 22 March 2019
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 166 (5) , 661-666
Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma
The antimetastatic activity of combined or individual administration of topotecan and tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitor was examined under various administration schedules in mice with Lewis lung carcinoma modeled by intravenous injection of 200,000 clone/mouse. The greatest antimetastatic effect was observed after combined use of topotecan and Tdp1 inhibitor as documented by macroscopic study of the lungs that revealed the decreased metastatic scores by 76, 91, or 74% at the respective inhibitor doses of 2, 4, or 6 mg/mouse, respectively, in parallel with inhibition of metastasis up to 98% (at inhibitor dose of 4 mg/mouse) and morphological and morphometric analyses of the lung sections, which revealed elevation of metastasis growth delay index to 86 and 63% at the respective inhibitor doses of 4 and 6 mg/mouse, respectively. The combined administration of topotecan and Tdp1 inhibitor is viewed as the most effective way to eliminate the metastatic formations with possible restitution of focal lesions.